A roundtable event for BIO and Bay Bio members on regulatory and reimbursement policy will be held on Monday, October 17th at 5:00-7:00 p.m. at the BayBio Offices at 395 Oyster Point Blvd., Suite 117, South San Francisco, CA 94080. The roundtable will focus on the industry’s policy agenda in Washington and BIO’s capital formation agenda with a specific focus on Sarbanes-Oxley and stock option expensing as well as its comprehensive tax legislation. For more information contact Jodie Rothschild or Laura Cornachio at BIO, 1225 Eye Street, Suite 400, NW, Washington, D.C. 20005, 202.962.6630.